Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants

No Thumbnail Available
Authors
Wallace, Christopher G
Yen, C-H
Yang, H-C
Lin, C-Y
Wu, R-C
Huang, W-C
Lin, J-Y
Wei, F-C
Journal
Clinical and Developmental Immunology
Type
Journal Article
Research Support, Non-U.S. Gov't
Publisher
Hindawi
Rights
Archived with thanks to Clinical and Developmental Immunology
Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and VCA rejection.
Citation
Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants 2012, 2012:1 Clinical and Developmental Immunology
Note
This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.